Skip to main content
SpringerLink
Log in

Cos’è la sclerosi multipla

  • Chapter
Aspetti psicologici nella sclerosi multipla

Riassunto

La sclerosi multipla (SM) è una malattia infiammatoria e neurodegenerativa del sistema nervoso centrale (SNC) di cui non si conoscono le cause patogeniche (Tabella 1.1), sebbene sia stata ormai accettata la sua natura autoimmunitaria, che si manifesta su una base genetica con l’interazione di fattori ambientali (The International MS Genetics Consortium & the Wellcome Trust Case Control Consortium, 2011).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Letture consigliate

  • Axtell RC, Raman C, Steinman L (2011) Interferon-β exacerbates Th17-mediated inflammatory disease. Trends Immunol 32(6):272–277

    Article  PubMed  Google Scholar 

  • Baranzini SE, Mudge J, Van Velkinburgh JC et al (2010) Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis. Nature 464(7293):1351–1358

    Article  Google Scholar 

  • Berer K, Wekerle H, Krishnamoorthy G (2011) B cells in spontaneous autoimmune diseases of the central nervous system. Mol Immunol 48(11):1332–1337

    Article  Google Scholar 

  • Bergamaschi R (2007) Prognostic factors in multiple sclerosis. Int Rev Neurobiol 79:423–447

    Article  PubMed  Google Scholar 

  • Cocco E, Sardu C, Massa R et al (2011) Epidemiology of multiple sclerosis in south-western Sardinia. Mult Scler 17(11):1282–1289

    Article  PubMed  Google Scholar 

  • Corey-Bloom J, Davir RB (2010) Clinical adult neurology. Chapter 20: demyelinating diseases. 3rd edn. Demos Medical Publishing, New York, pp. 363–375

    Google Scholar 

  • Ebers GC, Kukay K, Bulman DE et al (1996) A full genome search in multiple sclerosis. Nat Genet 13(4):472–476

    Article  PubMed  Google Scholar 

  • Fletcher JM, Lalor SJ, Sweeney CM et al (2010) T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 162(1):1–11

    Article  PubMed  Google Scholar 

  • Freedman MS (2011) Improving long-term follow up studies of immunomodulatory therapies. Neurology 76(suppl 1):S35–38

    Article  PubMed  Google Scholar 

  • Greer JM, McCombe PA (2011) Role of gender in multiple sclerosis: Clinical effects and potential molecular mechanisms. J Neuroimmunol 234(l–2):7–18

    Article  PubMed  Google Scholar 

  • Hall SW, Cooke A (2011) Autoimmunity and inflammation: murine models and translational studies. Mamm Genome 22(7–8):377–389

    Article  PubMed  Google Scholar 

  • Hoffjan S, Akkad DA (2010) The genetics of multiple sclerosis: An update 2010. Mol Cell Probes 24(5):237–243

    Article  PubMed  Google Scholar 

  • Lassmann H (1998) Neuropathology in multiple sclerosis: new concepts. Mult Scler 4(3):93–98

    PubMed  Google Scholar 

  • Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46(4):907–911

    Article  PubMed  Google Scholar 

  • Marriott JJ, O’Connor PW (2010) Emerging therapies in relapsing-remitting multiple sclerosis. Rev Recent Clin Trials 5(3):179–188

    Article  PubMed  Google Scholar 

  • Mc Donald I (1998) Diagnostic methods and investigation in multiple sclerosis. In: Compston A, Ebers G, Lassmann H et al (eds) Mc Alpine’s multiple sclerosis, 3rd edn. Churchill Livingstone, London, pp. 251–279

    Google Scholar 

  • McDonald WI, Compston A, Edan G et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neuro l50(1):121–127

    Article  Google Scholar 

  • Miller RH, Fyffe-Maricich SL (2010) Restoring the balance between disease and repair in multiple sclerosis: insights from mouse models. Dis Model Mech 3(9–10):535–539

    Article  PubMed  Google Scholar 

  • Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Medical progress: multiple sclerosis. N Engl J Med 343(13):938–952

    Article  PubMed  Google Scholar 

  • Orton SM, Herrera BM, Yee IM et al (2006) Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 5(11):932–936

    Article  PubMed  Google Scholar 

  • Polman CH, Reingold SC, Edan G et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 58(6):840–846

    Article  PubMed  Google Scholar 

  • Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald Criteria. Ann Neurol 69(2):292–302

    Article  PubMed  Google Scholar 

  • Pugliatti M, Sotgiu S, Rosati G (2002) The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg 104(3):182–191

    Article  PubMed  Google Scholar 

  • Racke MK, Lovett-Racke AE (2011) Glatiramer acetate treatment of multiple sclerosis: an immunological perspective. J Immunol 186(4):1887–1890

    Article  PubMed  Google Scholar 

  • Ramagopalan SV, Dobson R, Meier UC, Giovannoni G (2010) Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol 9:727–739

    Article  PubMed  Google Scholar 

  • Ristori G, Cannoni S, Stazi MA et al (2006) Multiple sclerosis in twins from continental Italy and Sardinia: A nationwide study. Ann Neurol 59(1):27–34

    Article  PubMed  Google Scholar 

  • Robertson NP, Fraser M, Deans J et al (1996) Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain 119(Pt 2):449–455

    Article  PubMed  Google Scholar 

  • Salvetti M, Giovannoni G, Aloisi F (2009) Epstein-Barr virus and multiple sclerosis. Curr Opin Neurol 22(3):201–206

    Article  PubMed  Google Scholar 

  • Sellner J, Kraus J, Awad A et al (2011) The increasing incidence and prevalence of female multiple sclerosis — a critical analysis of potential environmental factors. Autoimmun Rev 10(8):495–502

    Article  PubMed  Google Scholar 

  • The International MS Genetics Consortium & the Wellcome Trust Case Control Consortium (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476(7359):214–219

    Article  Google Scholar 

  • Vosoughi R, Freedman MS (2010) Therapy of MS. Clin Neurol Neurosurg 112(5):365–385

    Article  PubMed  Google Scholar 

  • Whitacre CC (2001) Sex differences in autoimmune disease. Nat Immunol 2(9):777–780Willer CJ, Dyment DA, Risch NJ et al (2003) Twin concordance and sibling recurrence rates in multiple sclerosis. PNAS 100(22):12877-12882

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. SCDO Neurologia 2 — CRESM (Centra di Riferimento Regionale Sclerosi Multipla), AOU S. Luigi Gonzaga, Orbassano (TO), Italia

    A. Bertolotto

Authors
  1. A. Bertolotto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Caricati
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Bertolotto .

Editor information

Editors and Affiliations

  1. Onorario di Psicologia dello Sviluppo e dell’Educazione Dipartimento di Psicologia, Università di Torino, Italia

    Silvia Bonino (Professore) (Professore)

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Italia

About this chapter

Cite this chapter

Bertolotto, A., Caricati, E. (2013). Cos’è la sclerosi multipla. In: Bonino, S. (eds) Aspetti psicologici nella sclerosi multipla. Springer, Milano. https://doi.org/10.1007/978-88-470-2724-4_1

Download citation

Publish with us

Policies and ethics

Search

Navigation